Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachael Liu

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Clinical Trials (London, England)|July 8, 2025
BARD: A seamless two-stage dose optimization design integrating backfill and adaptive randomizationYixuan Zhao, Rachael Liu, Jianchang Lin, et al.
Journal of Biopharmaceutical Statistics|November 28, 2025
M-DODII: Bayesian dose optimization design for randomized phase II study with multiple indicationsSasha Amdur Kravets, Ziji Yu, Rachael Liu, et al.
Pharmaceutical Statistics|December 10, 2025
Optimizing Dosing Strategies in Cell Therapy With Machine Learning and Exposure-Response IntegrationShuqi Wang, Yunqi Zhao, Jia Li, et al.
Journal of Biopharmaceutical Statistics|March 12, 2024
DOD-Combo: Bayesian dose finding design in combination trials with meta-analytic-predictive priorKai Chen, Yunqi Zhao, Meizi Liu, et al.
Journal of Biopharmaceutical Statistics|March 5, 2020
Bayesian Semi-parametric Design (BSD) for adaptive dose-finding with multiple strataMo Li, Rachael Liu, Jianchang Lin, et al.
The AAPS Journal|January 5, 2022
Machine Learning and Artificial Intelligence in Pharmaceutical Research and Development: a ReviewSheela Kolluri, Jianchang Lin, Rachael Liu, et al.
Journal of Biopharmaceutical Statistics|November 29, 2024
DOD-BART: machine learning-based dose optimization design incorporating patient-level prognostic factors via Bayesian additive regression treesYunqi Zhao, Rachael Liu, Jianchang Lin, et al.
Therapeutic Innovation & Regulatory Science|February 25, 2025
Optimizing Quality Tolerance Limits Monitoring in Clinical Trials Through Machine Learning MethodsLei Yan, Ziji Yu, Liwen Wu, et al.
Statistics in Medicine|April 10, 2024
A Bayesian platform trial design with hybrid control based on multisource exchangeability modellingWei Wei, Ondrej Blaha, Denise Esserman, et al.
Clinical Drug Investigation|March 29, 2017
The Effect of Food on Doravirine Bioavailability: Results from Two Pharmacokinetic Studies in Healthy SubjectsMartin O Behm, Ka Lai Yee, Rachael Liu, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Clinical Trials (London, England)|July 8, 2025
BARD: A seamless two-stage dose optimization design integrating backfill and adaptive randomizationYixuan Zhao, Rachael Liu, Jianchang Lin, et al.
Journal of Biopharmaceutical Statistics|November 28, 2025
M-DODII: Bayesian dose optimization design for randomized phase II study with multiple indicationsSasha Amdur Kravets, Ziji Yu, Rachael Liu, et al.
Pharmaceutical Statistics|December 10, 2025
Optimizing Dosing Strategies in Cell Therapy With Machine Learning and Exposure-Response IntegrationShuqi Wang, Yunqi Zhao, Jia Li, et al.
Journal of Biopharmaceutical Statistics|March 12, 2024
DOD-Combo: Bayesian dose finding design in combination trials with meta-analytic-predictive priorKai Chen, Yunqi Zhao, Meizi Liu, et al.
Journal of Biopharmaceutical Statistics|March 5, 2020
Bayesian Semi-parametric Design (BSD) for adaptive dose-finding with multiple strataMo Li, Rachael Liu, Jianchang Lin, et al.
The AAPS Journal|January 5, 2022
Machine Learning and Artificial Intelligence in Pharmaceutical Research and Development: a ReviewSheela Kolluri, Jianchang Lin, Rachael Liu, et al.
Journal of Biopharmaceutical Statistics|November 29, 2024
DOD-BART: machine learning-based dose optimization design incorporating patient-level prognostic factors via Bayesian additive regression treesYunqi Zhao, Rachael Liu, Jianchang Lin, et al.
Therapeutic Innovation & Regulatory Science|February 25, 2025
Optimizing Quality Tolerance Limits Monitoring in Clinical Trials Through Machine Learning MethodsLei Yan, Ziji Yu, Liwen Wu, et al.
Statistics in Medicine|April 10, 2024
A Bayesian platform trial design with hybrid control based on multisource exchangeability modellingWei Wei, Ondrej Blaha, Denise Esserman, et al.
Clinical Drug Investigation|March 29, 2017
The Effect of Food on Doravirine Bioavailability: Results from Two Pharmacokinetic Studies in Healthy SubjectsMartin O Behm, Ka Lai Yee, Rachael Liu, et al.
Pageof 4